Screener
Aquestive Therapeutics, Inc. AQST PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000042
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Inventories | 7,366 | 6,169 |
| Prepaid expenses and other current assets | 3,312 | 4,168 |
| Total current assets | 118,494 | 149,269 |
| Property and equipment, net | 3,960 | 3,893 |
| Right-of-use assets, net | 7,949 | 4,621 |
| Other non-current assets | 1,701 | 2,642 |
| Total assets | $132,104 | $160,425 |
| Liabilities and stockholders’ deficit |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Aquestive Therapeutics, Inc.'s PP&E (net)?
- Aquestive Therapeutics, Inc. (AQST) reported PP&E (net) of $3.96M in Q2 2026.
- How has Aquestive Therapeutics, Inc.'s PP&E (net) changed year-over-year?
- Aquestive Therapeutics, Inc.'s PP&E (net) increased by 2.6% year-over-year, from $3.86M to $3.96M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s PP&E (net) has grown at a -10.7% compound annual growth rate (CAGR), from $6.87M to $3.89M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Aquestive Therapeutics, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude